Related Experiment Video
Updated: May 21, 2026

09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Douglas G Altman1, Lisa M McShane, Willi Sauerbrei
1Centre for Statistics in Medicine, University of Oxford, UK. doug.altman@csm.ox.ac.uk
BMC Medicine
|May 31, 2012
Summary
This study elaborates on the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist to improve the reporting quality of tumor marker studies. It provides guidance on transparently reporting research goals, methods, and results for better medical research.
Area of Science:
- Biostatistics
- Biomedical Research Methodology
- Oncology
Background:
- The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist addresses deficiencies in reporting tumor marker studies.
- This paper expands the REMARK checklist to enhance its utility and effectiveness.
- It clarifies the intent and importance of each reporting item.
Purpose of the Study:
- To provide a comprehensive overview and reference for good reporting practices in tumor marker and prognostic studies.
- To enhance the understanding and application of the REMARK checklist.
- To improve the transparency and quality of published medical research.
Main Methods:
- The study elaborates on each item of the REMARK checklist.
- It includes explanations, examples of good reporting, and empirical evidence.
- A tabular format, the 'REMARK profile,' is proposed for summarizing key study details.
Main Results:
- The expanded REMARK checklist offers a clearer understanding of reporting requirements.
- Examples and evidence support the importance of each checklist item.
- The 'REMARK profile' provides a structured way to present study information.
Conclusions:
- This work serves as a valuable educational resource for designing, conducting, and analyzing prognostic studies.
- It aims to improve the quality and transparency of tumor marker research reporting.
- The article is published in PLoS Medicine to maximize dissemination.